Better vaccines and new antivirals: Study identifies immune checkpoint as potential target to strengthen the innate immune response

Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new regulator of the innate immune response-the immediate, natural immune response to foreign invaders. The study, published recently in Nature Microbiology, suggests that therapeutics that modulate the regulator-an immune checkpoint-may represent the next generation of antiviral drugs, vaccine adjuvants, cancer immunotherapies, and treatments ["]

The post Better vaccines and new antivirals: Study identifies immune checkpoint as potential target to strengthen the innate immune response appeared first on Outbreak News Today.